Symptoms

• Should Your Patient Be Tested
• Your Newly Diagnosed Patient
• Managing Your AAT Deficient Patient

AlphaTest® Kit

Request our complimentary AlphaTest® Kit today. It makes testing for AAT deficiency as easy as a finger-stick blood test.

 

eLearning Program

View our eLearning Program to learn more about Alpha-1

 

Patients with AAT deficiency usually present with the following symptoms:

• Shortness of breath
• Decreased exercise capacity
• Wheezing
• Chronic cough
• Frequent respiratory infections

The symptoms of AAT deficiency are similar to those of other pulmonary conditions, in particular emphysema and asthma. The similarity in the clinical presentations contributes to the fact that AAT-deficiency emphysema is frequently under-recognized by physicians. It is estimated that only 5% of AAT deficient patients have been identified.¹

ARALAST [Alpha₁-Proteinase Inhibitor (Human)] is indicated for chronic augmentation therapy in patients having congenital deficiency of A₁-PI with clinically evident emphysema. ARALAST is not indicated as therapy for lung disease patients in whom congenital A₁-PI deficiency has not been established.

Please review the Important Safety Information and the Full Prescribing Information